A randomized, open label trial of olanzapine versus lithium in the treatment of acute depression in patients with bipolar II or bipolar not otherwise specified.
Phase 4
- Conditions
- Bipolar II disorder or Bipolar disorder not otherwise specified(NOS)
- Registration Number
- JPRN-UMIN000015124
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 236
Inclusion Criteria
Not provided
Exclusion Criteria
1)don't have Diabetes and abnormal metabolism of sugar 2)not noticed as bipolar disorder. 3)have an organic brain disease. 4)pregnant or breastfeeding women. 5)don't have heart disease. 6)have actively suicidal thought(Suicidal ideation score of MADRS is 6). 7)who are judged by the investigator to should be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method